Successful DrugFinder Collaboration with Oxford University Chemistry Department Discovers Novel Kinase Inhibitors

Oxford, UK - November 2009

As part of its DrugFinder initiative, InhibOx has undertaken a project in collaboration with the group of Dr. Angela Russell of the Chemistry Department, at the University of Oxford.  Taking an oncology kinase target as its starting point, InhibOx performed virtual screening of its internal databases, using its proprietary software platform to identify potential inhibitors for experimental screening.

The experimental screening results have identified compounds of great interest, which are being actively pursued.